Navigation Links
Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine
Date:12/23/2008

Smokers who have an easier time quitting may have the benefit of specific genes that can foster success, according to a new study by a team of federal scientists at the National Institute on Drug Abuse.

Manhasset, NY (Vocus) December 23, 2008 -- Smokers who have an easier time quitting may have the benefit of specific genes that can foster success, according to a new study by a team of federal scientists at the National Institute on Drug Abuse. Tomas Drgon, Dean Hamer, George Uhl and their colleagues conducted genome-wide association studies on volunteers with smoking histories and symptoms of nicotine dependence, who were able to successfully stop smoking in community settings, "outside of the somewhat artificial setting of a clinical trial," the authors wrote. The subjects had a specific SNP, single nucleotide polymorphism, which made it easier to stop smoking and remain abstinent. There were SNPs that were more common among those who had trouble quitting and those who stopped without much trouble. In short, subjects who smoke or have smoked had a different genetic allele frequency than those who never smoked. Other researchers have also found similar patterns in genome-wide association studies with cigarettes and other drugs of abuse - a phenotype of substance dependence.

The authors did not find genetic linkage in social smokers (people who smoked at low and steady levels but who were not dependent on cigarettes).

These findings are "reassuring for future attempts to use genotype-based data to match smokers with the type and/or intensities of treatments that provide the best and most cost-effective smoking cessation opportunities for them in community settings," the authors wrote.

Other studies in the January-February 2009 issue of Molecular Medicine include ''Transcriptional Control of Chronic Fatigue Syndrome'' and ''Human AM/AMBP1 as a Treatment for Sepsis.''

Molecular Medicine is published by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. To read the journal online and view this month's popular podcast go to www.molmed.org. For more information contact Assistant Editor, Veronica Davis at 516-562-2670.

###

Read the full story at http://www.prweb.com/releases/Molecular/Medicine/prweb1789394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Rockefeller Universitys Center for Clinical and Translational Science funds 18 new pilot studies
2. Genome-wide Association Studies Must Account for Ancestry
3. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
4. Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagnosed or Relapsed or Refractory Non-Hodgkins Lymphoma
5. Dismissed leukemia drug helps cll patients, studies show
6. Studies examine quality of care for hospitalized sickle cell disease patients
7. FRC: New Mental Health Studies Dispel Myth That Abortion Is A Non-Event
8. MannKind Reports Positive Results from Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
9. Journal CHEST: December highlighted studies
10. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
11. MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 
(Date:3/24/2017)... ... ... Digital Scientists, a software innovation lab specializing in web design and ... Carolina location. The lab has set up shop at the renowned NEXT Innovation ... Carolina clients for years from our office here in Atlanta,” explains Digital Scientists’ CEO, ...
(Date:3/24/2017)... Lake Orion, MI (PRWEB) , ... March 24, ... ... providing insurance assistance, financial planning, and related services to families and business owners ... charity initiative aimed at feeding regional families struggling with financial difficulties. , The ...
(Date:3/24/2017)... CA (PRWEB) , ... March 24, 2017 , ... ... on two panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, ... Creating the Administrative Record, The majority of cases litigated under ERISA involve claims ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
(Date:3/23/2017)... 23, 2017 The key factors driving ... diabetic population, accelerating economic growth and increasing healthcare expenditure. Some ... higher life expectancy of ESRD patients, rising demand for home ... the expansion of the market is hindered by high treatment ... ...
(Date:3/23/2017)... 23, 2017 As a result of ... the prevalence of allergic diseases, cutting edge developments ... revolutionising the ways in which pharmaceutical and biotech ... promises to be both a high quality meeting ... interest groups, immunologists, research scholars and doctors. The ...
Breaking Medicine Technology: